Effects of pemafibrate on left ventricular diastolic function in patients with type 2 diabetes mellitus: a pilot study-Reference-Cited by-同舟云学术

Effects of pemafibrate on left ventricular diastolic function in patients with type 2 diabetes mellitus: a pilot study

Published:2023-07-19 Issue:4 Volume:14 Page:434-439
ISSN:2190-1678
Container-title:Diabetology International
language:en
Short-container-title:Diabetol Int

Author:

Yamamoto Kaoru,Ohta Yasuharu,Taguchi Akihiko,Akiyama Masaru,Nakabayashi Hiroko,Nagao Yuko,Ryoko Hatanaka,Wada Yasuaki,Yamamoto Takeshi,Yano Masafumi,Tanizawa Yukio

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13340-023-00645-x.pdf

Reference24 articles.

1. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30:595–602.

2. Jia G, DeMarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 2016;12:144–53.

3. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–12.

4. Jia G, Habibi J, Aroor AR, Martinez-Lemus LA, DeMarco VG, Ramirez-Perez FI, Sun Z, Hayden MR, Meininger GA, Mueller KB, Jaffe IZ, Sowers JR. Endothelial mineralcorticoid receptor deletion prevents diet-induced cardiac diastolic dysfunction in females. Hypertension. 2015;66:1159–67.

5. Ritterhoff J, Tian R. Metabolism in cardiomyopathy: every substrate matters. Cardiovasc Res. 2017;113:411–21.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The latest emerging drugs for the treatment of diabetic cardiomyopathy;Expert Opinion on Pharmacotherapy;2024-04-12